Goralatide Reference
Educational, not medical advice reference for Goralatide: Recovery, Longevity; regulatory status, evidence posture, source review, and schedule…
Plain English
- What it is
- Goralatide, also called Ac-SDKP, is a tiny natural piece of protein (a four-part chain called a tetrapeptide) that the body makes by snipping it off the end of a larger protein named thymosin beta-4. It is not an FDA-approved medicine for any condition. It is studied and traded as a research chemical, not a finished drug.
- What people use it for
- In lab and animal studies it has been looked at for calming inflammation and slowing fibrosis, which is the build-up of stiff scar tissue inside organs such as the heart, lungs, and kidneys. People interested in protecting those organs from scarring sometimes look at it for that reason.
- What the science shows
- Most of the supporting evidence comes from rodent (rat and mouse) studies, not from people. The handful of human studies have been small and early, and the most advanced one tested it as part of a kidney-function test rather than as an approved treatment. There is no large, strong proof that it works or is safe in humans.
- The catch
- It has no FDA approval, so it has not been shown to be safe or effective in people, and nearly all of the encouraging data is from animals. Human research stays small and exploratory. For research and educational purposes only. Not medical advice.
Reference summary
Published work is mostly preclinical, focused on antifibrotic activity in cardiac, pulmonary, and renal models. Clinical antifibrotic programs have been small and exploratory.
Regulatory and posture
- Categories
- Recovery, Longevity
- Aliases
- Ac-SDKP, N-acetyl-Seryl-Aspartyl-Lysyl-Proline
- Evidence posture
- preclinical - Mostly rodent antifibrotic data. Human clinical antifibrotic programs are exploratory and small. No FDA-approved indication.
- Regulatory status
- No FDA-approved Ac-SDKP / goralatide drug label. Ac-SDKP is the natural N-terminal tetrapeptide cleaved from thymosin beta-4 and has been studied as an antifibrotic and hematopoietic regulator.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed search: Ac-SDKP (goralatide) antifibrotic tetrapeptide literature
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.
For research and educational purposes only. Not medical advice.